98 related articles for article (PubMed ID: 8688142)
1. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptor.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1995 Nov; 50(11):755-9. PubMed ID: 8593172
[TBL] [Abstract][Full Text] [Related]
3. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
4. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
5. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of tripeptide FR113680 analogues containing unconventional amino acids.
Caliendo G; Calignano A; Grieco P; Mancuso F; Perissutti E; Santini A; Santagada V
Biopolymers; 1995 Oct; 36(4):409-14. PubMed ID: 7578938
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
[TBL] [Abstract][Full Text] [Related]
8. Effects of tachykinin receptor antagonists, FK224 and FK888, in a guinea-pig model of nasal allergy.
Katahashi T; Konno A
Rhinology; 1997 Jun; 35(2):63-6. PubMed ID: 9299653
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
10. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophan.
Caliendo G; Fiorino F; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Albrizio S
Farmaco; 1997 Oct; 52(10):589-93. PubMed ID: 9507670
[TBL] [Abstract][Full Text] [Related]
12. NK2 receptor-mediated spontaneous phasic contractions in normal and ulcerative colitis human sigmoid colon.
Cao W; Harnett KM; Pricolo VE
J Pharmacol Exp Ther; 2006 Jun; 317(3):1349-55. PubMed ID: 16554357
[TBL] [Abstract][Full Text] [Related]
13. Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists.
Gensini M; Altamura M; Dimoulas T; Fedi V; Giannotti D; Giuliani S; Guidi A; Harmat NJ; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
ChemMedChem; 2010 Jan; 5(1):65-78. PubMed ID: 19957262
[TBL] [Abstract][Full Text] [Related]
14. Studies on neurokinin antagonists. 4. Synthesis and structure-activity relationships of novel dipeptide substance P antagonists: N2-[(4R)-4-hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl]-N- methyl-N-(phenylmethyl)-3-(2-naphthyl)-L-alaninamide and its related compounds.
Hagiwara D; Miyake H; Igari N; Karino M; Maeda Y; Fujii T; Matsuo M
J Med Chem; 1994 Jun; 37(13):2090-9. PubMed ID: 7518002
[TBL] [Abstract][Full Text] [Related]
15. Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.
Mulè F; Amato A; Serio R
Eur J Pharmacol; 2007 Sep; 570(1-3):196-202. PubMed ID: 17597603
[TBL] [Abstract][Full Text] [Related]
16. Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs.
Yamamoto T; Hanioka N; Maeda Y; Imazumi K; Hamada K; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2003 Sep; 477(3):253-9. PubMed ID: 14522364
[TBL] [Abstract][Full Text] [Related]
17. [Discovery and pharmacological properties of selective neurokinin-receptor antagonists, FK224 and FK888].
Fujii T
Nihon Yakurigaku Zasshi; 1995 Sep; 106(3):193-204. PubMed ID: 8529964
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.
Fedi V; Altamura M; Catalioto RM; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Lecci A; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
J Med Chem; 2007 Oct; 50(20):4793-807. PubMed ID: 17850056
[TBL] [Abstract][Full Text] [Related]
19. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
